Identification of tipifarnib sensitivity biomarkers in T-cell acute lymphoblastic leukemia and T-cell lymphoma

Patients diagnosed with T-cell leukemias and T-cell lymphomas (TCLs) still have a poor prognosis and an inadequate response to current therapies, highlighting the need for targeted treatments. We have analyzed the potential therapeutic value of the farnesyltransferase inhibitor, tipifarnib, in 25 TC...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Sci Rep
Autores principales: Alonso-Alonso, Ruth, Mondéjar, Rufino, Martínez, Nerea, García-Diaz, Nuria, Pérez, Cristina, Merino, David, Rodríguez, Marta, Esteve-Codina, Anna, Fuste, Berta, Gut, Marta, Burrows, Francis, Scholz, Catherine, Vaqué, Jose Pedro, Gualberto, Antonio, Piris, Miguel Ángel
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7174413/
https://ncbi.nlm.nih.gov/pubmed/32317694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-63434-5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares